viewReal Good Food PLC

Real Good Food sells off Chantilly Patisserie business for £0.2mln

The sale to Chantilly’s management team means Real Good Food is now free to focus on its two profitable remaining divisions – cake decoration and ingredients

Chantilly Patisserie sells premium frozen desserts to pubs and restaurants up and down the UK

Real Good Food PLC (LON:RGD) has sold off its Chantilly Patisserie to the premium bakery’s management team for £200,000 in cash.

The sale means Real Good Food is now free to focus on its two profitable businesses – cake decoration (Renshaw and Rainbow Dust) and ingredients (Brighter Foods).

READ: RGF gets out of a jam with sale of R&W Scott

Last year, Chantilly, which supplies frozen desserts to pubs and restaurants up and down the UK, generated revenue of £2.4mln and made an underlying loss of £0.25mln.

“Following this disposal (and those of Haydens, Garretts and R&W Scott), RGF is now free to focus its full attention and resources on growing its two profitable, continuing businesses which together now comprise the majority of the group – Cake Decoration (Renshaw and Rainbow Dust) and Ingredients (Brighter Foods),” said

“Having transformed the Group's financial position as a result of these disposals and other financing activities, the financial resources are now available to fund this growth.”

Target weight reached

AIM-quoted RGF has been in slimming mode of late, offloading its loss-making divisions as it looks to stabilise after a tough couple of years which saw it post a string of profit warnings and overhaul its management.

Within the last year, the company has sold off its sugar supply business Garrett Ingredients, jam maker R&W Scott and Haydens, which makes premium pies and tarts.

In total, those sales, including that of Chantilly, have brought in around £18mln.

Quick facts: Real Good Food PLC

Price: 5.325 GBX

Market: LSE
Market Cap: £5.3 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

2 days, 21 hours ago

2 min read